Information about http://www.ottawamedtech.com/media_lib/Sept.9,_2008/Sept._9_Program.pdf

OttawaMEDTECH Breakfast Leveraging the NIH and NRC for Research,…

Tags: answer session, bethesda md, business support, business work, central business, commercialization, david mcinnes, external collaborations, group leader, industry collaboration, leader office, marketing group, medical technology companies, national institutes of health, national research council, nrc, opening remarks, ottawa hotel, research institutions, vice president international,
Pages: 1
Language: english
Created: Thu Aug 14 14:47:46 2008
Display cached document
Page 1
image
OttawaMEDTECH Breakfast
Leveraging the NIH and NRC for Research, Development
and Commercialization

September 9, 2008
Sheraton Ottawa Hotel
150 Albert Street
7:45   Registration, Networking and Breakfast

8:30   Opening Remarks
       David McInnes, Vice-President, International Relations, MDS Nordion;
       Chair, OttawaMEDTECH

8:40   Leveraging the NIH and NRC for Research, Development and Commercialization
       Ajoy Prabhu, Marketing Group Leader, Office of Technology Transfer, National Institutes of Health
       (Bethesda, MD)
       Judith Young, Executive Director, Central Business Support, National Research Council (Ottawa,
       ON)

       ·   How do the NIH and NRC enable innovation and competitiveness?
       ·   How are the NIH and NRC commercializing their own research?
       ·   What are the benefits of collaborating with the NRC and NIH?
       ·   What capabilities do the NIH and NRC offer to industry?
       ·   How do businesses access these capabilities?
       ·   What steps are the NRC and NIH taking to reach out to external players for the
           commercialization of their research?
       ·   What capabilities do your institutes have that would be of interest to medical technology
           companies?
       ·   How are businesses matched up with scientists and engineers?
       ·   Case studies of collaborations which have successfully led to the commercialization of a product
       ·   What is the protocol with respect to intellectual property and external collaborations?
       ·   What novel approaches have the NIH and NRC taken to better facilitate industry collaboration?
       ·   How should research institutions and business work together in the future?

10:00 Question and Answer Session

10:30 Seminar Ends